| Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis S Thebault, M Abdoli, SM Fereshtehnejad, D Tessier, V Tabard-Cossa, ... Scientific reports 10 (1), 10381, 2020 | 105 | 2020 |
| Blood neurofilament light chain: the neurologist’s troponin? S Thebault, RA Booth, MS Freedman Biomedicines 8 (11), 523, 2020 | 71 | 2020 |
| High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS S Thebault, D Tessier, L Hyunwoo, M Bowman, A Bar-Or, D Arnold, ... Neurology Neuroimmunology and Neuroinflammation 6, e598, 2019 | 55 | 2019 |
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis S Meier, EAJ Willemse, S Schaedelin, J Oechtering, J Lorscheider, ... JAMA neurology 80 (3), 287-297, 2023 | 50 | 2023 |
| Serum neurofilament light chain measurement in MS: hurdles to clinical translation S Thebault, RA Booth, CA Rush, H MacLean, MS Freedman Frontiers in Neuroscience 15, 654942, 2021 | 45 | 2021 |
| Serum neurofilament light in MS: The first true blood-based biomarker? S Thebault, G Bose, R Booth, MS Freedman Multiple Sclerosis Journal 28 (10), 1491-1497, 2022 | 39 | 2022 |
| Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination S Thebault, P Waters, MD Snape, D Cottrell, N Darin, T Hallböök, ... PLoS One 10 (6), e0129555, 2015 | 28 | 2015 |
| Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis S Thebault, H Lee, G Bose, D Tessier, M Abdoli, M Bowman, J Berard, ... Annals of Clinical and Translational Neurology 7 (5), 767-775, 2020 | 27 | 2020 |
| Narcolepsy and H1N1 vaccination: a link? S Thebault, A Vincent, P Gringras Current opinion in pulmonary medicine 19 (6), 587-593, 2013 | 23 | 2013 |
| High or increasing serum NfL is predictive of impending multiple sclerosis relapses S Thebault, M Reaume, RA Marrie, JJ Marriott, R Furlan, A Laroni, ... Multiple Sclerosis and Related Disorders 59, 103535, 2022 | 21 | 2022 |
| Autologous hematopoietic stem cell transplantation for multiple sclerosis: a current perspective G Bose, S Thebault, CA Rush, HL Atkins, MS Freedman Multiple Sclerosis Journal 27 (2), 167-173, 2021 | 12 | 2021 |
| Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy A Reilly, MO Deguise, A Beauvais, R Yaworski, S Thebault, DR Tessier, ... Gene Therapy 29 (9), 544-554, 2022 | 10 | 2022 |
| Implications of low-titer MOG antibodies M Levy, EA Yeh, CH Hawkes, J Lechner-Scott, G Giovannoni Multiple sclerosis and related disorders 59, 2022 | 10 | 2022 |
| Does resetting the immune system fix multiple sclerosis? G Bose, SDX Thebault, HL Atkins, MS Freedman Canadian Journal of Neurological Sciences 47 (1), 1-10, 2020 | 10 | 2020 |
| Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma. S Thebault, I Hanes, J Woulfe, P Bourque Neurology: Neuroimmunology and Neuroinflammation 6 (1), e527, 2018 | 10 | 2018 |
| Complement‐induced protection: an explanation for the limitations of cell‐based tumour immunotherapies E Kempshall, S Thebault, B Paul Morgan, CL Harris, A Gallimore Immunology and Cell Biology 90 (9), 869-871, 2012 | 9 | 2012 |
| Blood neurofilament light chain: the Neurologist’s Troponin? Biomedicines 8 (11): 523 S Thebault, RA Booth, MS Freedman | 5 | 2020 |
| Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury D Wilson, D Chan, L Chang, R Mathis, I Verberk, X Montalban, ... Clinical Chemistry and Laboratory Medicine (CCLM) 62 (2), 322-331, 2024 | 4 | 2024 |
| Autologous hematopoietic stem cell transplant in patients with severe refractory neuromyelitis optica spectrum disease: the Ottawa experience J Brooks, H Atkins, G Bose, S Thebault, M Freedman, C Rush MULTIPLE SCLEROSIS JOURNAL 25, 46-47, 2019 | 4 | 2019 |
| Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial JA Berard, MS Freedman, RA Marrie, JJ Marriott, HL Atkins, D Szwajcer, ... Multiple Sclerosis and Related Disorders 61, 103779, 2022 | 3 | 2022 |
